Avanos Medical, Inc.
AVNS
$24.97
$0.010.02%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -74.40M | -72.90M | -468.90M | -463.20M | -384.60M |
| Total Depreciation and Amortization | 39.50M | 38.90M | 40.10M | 42.40M | 43.70M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 89.20M | 88.50M | 492.50M | 486.90M | 412.90M |
| Change in Net Operating Assets | -17.60M | 20.20M | 40.70M | 47.30M | 62.40M |
| Cash from Operations | 36.70M | 74.70M | 104.40M | 113.40M | 134.40M |
| Capital Expenditure | -29.20M | -31.60M | -29.50M | -25.50M | -20.40M |
| Sale of Property, Plant, and Equipment | 4.00M | 4.00M | 4.00M | -- | -- |
| Cash Acquisitions | -28.00M | -28.00M | -28.30M | -- | -- |
| Divestitures | -- | -- | -2.10M | 0.00 | -2.10M |
| Other Investing Activities | -6.00M | -5.00M | -5.50M | -16.40M | -12.10M |
| Cash from Investing | -59.20M | -60.60M | -61.40M | -41.90M | -34.60M |
| Total Debt Issued | -- | -- | 0.00 | 0.00 | 0.00 |
| Total Debt Repaid | -9.40M | -34.40M | -59.30M | -70.20M | -69.30M |
| Issuance of Common Stock | 700.00K | 700.00K | 700.00K | 1.00M | 1.00M |
| Repurchase of Common Stock | -2.40M | -3.30M | -3.10M | -3.20M | -5.90M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | -3.30M | -3.30M |
| Cash from Financing | -11.10M | -37.00M | -61.70M | -75.70M | -77.50M |
| Foreign Exchange rate Adjustments | 2.20M | 5.00M | 200.00K | 2.30M | -1.10M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -31.40M | -17.90M | -18.50M | -1.90M | 21.20M |